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The human immunodeﬁciency virus type 1 (HIV-1) Tat protein
(transactivator of transcription) is a small basic protein of 86 up to
102 residues dependent on the viral isolate [1,2]. It is a key regulator
of viral gene expression and stimulates transcription of viral genes
about 10- to 100-fold above basal transcription levels at the stage of
transcription elongation [2]. The protein is also involved in other steps
of virus production and it is known to be strictly required for HIV-1
multiplication within infected cells [3]. However, the protein is not
restricted to infected cells. Albeit devoid of a signal sequence, it is
released by infected cells [4] and nanomolar Tat concentrations were
measured in the sera of HIV-1-infected patients [5]. If the Tat proteinenters non-infected cells, the replication cycle of the virus becomes
more efﬁcient after infection. Based on those effects found for
extracellular Tat, it is suggested that it is involved in the progression
to AIDS [1,6], and is thus considered an important target in the
development of anti-HIV-1 drugs or vaccines [4,7].
To elicit cell responses, Tat needs to reach the inside of the cell,
which might occur ﬁrst via clathrin-mediated endocytosis [8]. It then
accumulates in late endosomes, from where it has to escape to reach
the cytosol and eventually localize to the nucleus. The molecular
determinants that enable Tat to cross membranes as well as the
membrane translocation mechanism still remain elusive.
As yet, a wealth of information has been gathered only for the HIV-1
Tat peptide, which corresponds to a 10 amino acid long basic region (aa
48–57) of the full length protein (Fig. 1). This peptide is capable of
crossing plasma membranes of living cells within 3–5 min [9]. Fused to
various cargo moieties, Tat peptide can even deliver ﬂuorophores,
nucleotides, proteins, drugs and genes into cells [10–16]. Its sequence
comprises two lysine and six arginine residues, which makes the
peptide strongly cationic (also called arginine-rich motif, ARM). From a
structural and functional perspective, the Tat peptide belongs to the
class of cell penetrating peptides (CPPs), which are generally composed
of 10–30 amino acids containing a cluster of positively charged arginine
and lysine residues. Such CPPs have been shown to cross artiﬁcial
membranes and they are able to form pores [17–26]. In vitro studies
demonstrated that pore formation also occurs during the interaction of
Tat peptide with artiﬁcial membranes [27]. It has been further
Fig. 1. Schematic drawings of the different structural regions of full length Tat and the N-terminally truncated protein. For comparison, the basic cluster of the Tat peptide (arginine-
rich motif, ARM) is shown.
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in the formation of inverted micelles [28]. Themembrane interaction of
Tat peptide is primarily driven by electrostatic forces arising from the
interaction of the peptide's positive net charge with the negative
charges of the phosphate groups of the lipids [29]. Non-electrostatic
forces, such as hydrogen bonding and van-der-Waals forces support
binding of the peptide as concluded from its binding energies [30].
Compared to the Tat peptide, much less is known about the
membrane interaction of full length Tat (aa 1–86), which comprises
not only the Tat peptide sequence but also several other motifs
(Fig. 1). The ﬁrst 21 N-terminal amino acids encompass an acidic and
proline-rich region containing a highly conserved tryptophan residue
at position 11 in HIV-1. It has been demonstrated that the Tat protein
is capable of inserting into lipid monolayers and bilayers even though
the overall hydrophobicity of the protein is rather low. The
tryptophan residue at position 11 appears to be crucial for this
insertion [31]. This stretch is followed by a cysteine-rich region (aa
22–37), a highly conserved core sequence (aa 38–47), the basic region
(aa 48–57), and a glutamine-rich segment (aa 58–72) [32]. The
second exon includes an RGD-motif that may mediate Tat binding to
cell surface integrins [33]. The cysteine-rich region can form a zinc
ﬁnger motif, and it has been demonstrated that full length Tat can
form metal-linked dimers [34]. The overall structure of the protein is,
however largely unfolded as deduced from CD-spectroscopy [35] and
NMR-spectroscopy [36] of a reduced HIV-1 Tat (1–72) and rather
ﬂexible.
As full length Tat (aa 1–86) is structurally greatly different from Tat
peptide (aa 48–57) (Fig. 1), the question needs to be answered whether
the mechanism by which the protein interacts and potentially crosses a
membrane is the same as that observed for the Tat peptide, i.e.whether it
is capable of forming pores. Thus, we performed experiments with full
length Tat using large unilamellar vesicles (LUVs) and giant unilamellar
vesicles (GUVs) in conjunction with ﬂuorescence spectroscopy and
ﬂuorescence microscopy. To be able to elucidate the inﬂuence of the
structurally most deﬁned region of the protein, the cysteine-rich region,
wemade use of an N-terminally truncated version of the protein lacking
the ﬁrst 34 amino acids (Fig. 1).
2. Materials and methods
2.1. Materials
The phospholipids POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
phocholine) and Bio-cap-PE (1,2-dipalmitoyl-sn-glycero-3-phos-
phoethanolamine-N-cap-biotinyl, sodium salt) were purchased from
Avanti Polar Lipids Inc. (Alabaster, AL, USA). TR-DHPE (sulforhodamine
101 dihexadecanoylphosphatidylethanolamine) and avidin were
obtained from Sigma-Aldrich (Taufkirchen, Germany), PB-DMPE (pa-
ciﬁc blue-1,2-ditetradecanoyl-sn-glycero-3-phosphoethanolamine,triethylammonium salt) Alexa Fluor 488, dextran coupled Alexa
Fluor 488 and Alexa Fluor 633-C5-maleimide were obtained from
Invitrogen GmbH (Karlsruhe, Germany). The lipids were dissolved
in chloroform. The water soluble dye pyranine (8-hydroxy-1,3,6-
pyrenetrisulfonic acid, trisodium salt) was purchased from Acros
Organics (Geel, Belgium). P-type silicon wafers (with 100 nm SiO2,
speciﬁc resistance=1–20 Ω cm) were purchased from CrysTec
(Berlin, Germany). Water was puriﬁed ﬁrst through a Millipore
water-puriﬁcation system Milli-RO 3 plus and ﬁnally with a
Millipore ultrapure water system Milli-Q plus 185 (speciﬁc resis-
tance=18.2 MΩ cm−1) (Billerica, MA, USA).
2.2. Protein expression and puriﬁcation
Genes encoding full length Tat (aa 1–86) and N-terminally truncated
Tat (aa 35–86)were cloned into the prokaryotic expression vector pGEX-
4T-1 (GE Healthcare) modiﬁed with a TEV cleavage site to generate a
fusion protein with an N-terminal glutathione-S-transferase (GST) tag.
Proteins were expressed and puriﬁed similarly as described [37]. Brieﬂy,
Tat proteinswere expressed in Escherichia coliBL21(DE)3 cells (Novagen)
for 4 h after induction with 0.1 mM IPTG. Cells were lysed in buffer A
(20 mM Tris/HCl, 500 mMNaCl, 10% glycerol, 5 mM β-mercaptoethanol,
pH 7.4) supplemented with 1 mM PMSF. The lysate was cleared by
centrifugation for30 minat 32,000×gand the supernatantwas applied to
a GSH-Sepharose (GEHealthcare) columnpre-equilibratedwith buffer A.
The column was washed with buffer A, followed by 10 column volumes
buffer A containing 1 M NaCl. An on-column cleavage with TEV protease
in buffer A was performed to cleave off the GST-tag. Tat protein was
washed from the column with buffer B (50 mM Tris/HCl, 200 mM NaCl,
10%glycerol, 5 mMβ-mercaptoethanol, pH7.4), uncleaved fusionprotein
and GST were eluted with buffer B supplemented with 10 mM GSH.
Fractions containing Tat protein were pooled and diluted in buffer C
(50 mMHEPES, 10% glycerol, 5 mMβ-mercaptoethanol, pH7.5) to aﬁnal
maximum salt concentration of 40 mM NaCl. The protein was further
puriﬁed using a 5 mLHiTrap SPXL column (GEHealthcare). Elution of the
protein was achieved with 0–1MNaCl in buffer C using a linear gradient
of 12 column volumes. Peak fractions were analyzed by SDS-PAGE. Tat
containing fractions were pooled, concentrated and stored at −80 °C
after ﬂash-freezing in liquid nitrogen.
2.3. Protein labeling
Alexa Fluor 633 (AF633)-C5-maleimide was dissolved in buffer
(20 mM Tris/HCl, 100 mM NaCl, pH 7.4) to a concentration of 1 mM.
210 μL of the dye solution was added to the protein solution (800 μL,
26.4 μM full length Tat (aa 1–86) dissolved in the same buffer) and
stirred at 4 °C overnight. Then, the reaction was quenched with an
excess of β-mercaptoethanol. Labeled full length Tat (aa 1–86),
termed Tat-AF633, was puriﬁed by FPLC (Äkta puriﬁer UPC 10, GE
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The concentration of Tat-AF633 and the labeling rate was determined
by UV/vis–spectroscopy at λ=280 nm (εTat=9970 L mol−1 cm−1),
taking the absorption of free AF633 at 280 nm into account (see
supplementary information, Figure S1).
2.4. Preparation of large unilamellar vesicles (LUVs)
Lipid ﬁlms composed of POPCwere prepared at the bottom of glass
test tubes by drying the lipids dissolved in chloroform under a stream
of nitrogen while heating above 30 °C followed by 3 h under vacuum.
The lipid ﬁlms were stored at 4 °C. Multilamellar vesicles were
obtained by incubating the lipid ﬁlm in 5(6)-carboxyﬂuorescein (CF)
containing buffer (100 mMCF, 20 mM Tris/HCl, 100 mMNaCl, pH 7.4)
for 30 min followed by vortexing it three times for 30 s every 5 min.
The resulting multilamellar vesicles were converted into LUVs by the
extrusion method using a polycarbonate membrane with a pore
diameter of 1000 nm. After formation of LUVs, the external ﬂuores-
cence dye was removed from the vesicles by gel ﬁltration using a
Sephadex G-25 column with NaCl containing buffer as eluent (20 mM
Tris/HCl, 100 mM NaCl, pH 7.4).
2.5. Preparation of giant unilamellar vesicles (GUVs)
POPC was used for GUV formation, 1 mol% of Bio-cap-PE was
added to ﬁx the GUVs on avidin coated silicon substrates. Moreover,
for ﬂuorescence labeling, 0.1 mol% of either TR-DHPE or PB-DMPEwas
added. GUVs were formed by electroformation. 25 μL of the respective
lipid mixture in chloroform were placed onto an indium tin oxide
(ITO) coated cover slip. After removing of the solvent, the lipid ﬁlm
was dissolved in 300 mM sucrose in ultrapure water and GUVs were
formed at 1.6 V and 12 Hz for 3 h. The successful formation of GUVs
was proven by confocal laser scanning microscopy (CLSM).
2.6. Release experiments
The release of 5(6)-carboxyﬂuorescein (CF) from LUVs composed
of POPC was monitored by the time dependent increase in
ﬂuorescence intensity of CF after addition of full length Tat (aa 1–
86) andN-terminally truncated Tat (aa 35–86). Fluorescence emission
of CF was measured at λem=520 nm, while it was excited at
λex=490 nm. To determine the maximum ﬂuorescence intensity F0,
the LUVs were destroyed by adding 2 μL of the detergent Triton X-100
(10% (w/v)) to a total volume of 800 μL. All experiments were
performed using the ﬂuorometer FP6500 (Jasco, Gotha, Germany).
2.7. GUV based assays
First, the silicon substrates were cleaned with isopropanol and
ultrapure water. Then, the silicon substrates were incubated in an
aqueous solution of NH3/H2O2 (H2O/NH3/H2O2, 5:1:1) for 15 min at
70 °C. The cleaned substrates were rinsed with ultrapure water and
mounted in an open Teﬂon chamber. For avidin coating, they were
incubated for 1 h with 200 μL of a 50 nM avidin solution in buffer
(20 mM Tris/HCl, 100 mM NaCl, pH 7.4). Finally, the substrates were
rinsed with buffer.
For the pore formation assay, 100 μL of the GUV suspension, which
were ﬁlled with 300 mM sucrose, were dissolved in buffer solution
containing 0.5 μM full length Tat (aa 1–86) or the N-terminal
truncated Tat (aa 35–86). The solution was added to the avidin
coated silicon substrate, where the GUVs were allowed to bind via
biotin to the avidin monolayer for about 10 min.
For the translocation assay, 20 μL of the GUV suspension were
dissolved in buffer solution containing 0.5 μM full length Tat-AF633.
The solution was again added to an avidin coated silicon substrate to
bind the GUVs onto the substrate. Fluorescence images of the GUVswere obtained in a time resolved manner. The same experiments
were performed in the presence of the water soluble dyes Alexa Fluor
488 (AF488), 3 kDa dextran coupled Alexa Fluor 488 (D3-AF488) and
10 kDa dextran coupled Alexa Fluor 488 (D10-AF488).
2.8. Confocal laser scanning microscopy
Fixed GUVs were visualized with an upright confocal laser
scanning microscope (LSM 710, Carl Zeiss AG, Jena, Germany) with
a water immersion objective W Plan-Apochromat 63×/1,0 VIS-IR. The
ﬂuorescent dyes TR-DHPE and PB-DMPE were excited at λ=594 nm,
and λ=405 nm, respectively. The water soluble dyes pyranine, Alexa
Fluor 488 and the dextran coupled Alexa Fluor 488 were excited at
λ=488 nm and Tat-AF633 at λ=633 nm. Fluorescence image
analysis was performed using the ZEN software (Carl Zeiss AG, Jena,
Germany).
3. Results
Previously, it has been shown that the cell penetrating HIV-1 Tat
peptide comprising amino acids 48–57 is capable of forming pores in
lipid bilayers of giant unilamellar vesicles (GUVs) dependent on the
lipid composition [38,39], while there was no pore formation
observed in large unilamellar vesicles (LUVs) [30,40–42]. Pore
formation or disruption of the bilayer structure can provide a pathway
for the highly charged peptide to cross lipid membranes, which might
be inﬂuenced by the membrane curvature. Thus, we ﬁrst addressed
the question whether the native full length Tat protein (aa 1–86) can
form pores in LUVs and GUVs, respectively. Besides the full length
protein, we used an N-terminally truncated protein (aa 35–86), which
lacks the proline- and cysteine-rich regions that are structurally most
deﬁned [43], but still harbors the arginine rich motif (basic cluster)
(Fig. 1). CD-spectra reveal no signiﬁcant structural differences
between full length Tat and the truncated version of the protein.
Both proteins adopt a predominant random coil conformation in
solution as reported previously (see supplementary information,
Figure S2) [35,36].
3.1. Pore formation induced by Tat proteins in LUVs
The release of 5(6)-carboxyﬂuorescein (CF) from LUVs is a well
known method to investigate pore formation processes in lipid
bilayers by water soluble peptides or proteins [44,45]. The method is
based on the self-quenching of CF at high concentrations (cN50 mM)
entrapped in the inner volume of the vesicles. When a protein or
peptide perturbs the bilayer integrity, CF is released, which leads to an
increase in ﬂuorescence intensity as a result of its dilution. Here, the
relative ﬂuorescence intensity was measured in a time dependent
manner. First, the ﬂuorescence intensity of the CF-ﬁlled POPC LUVs
wasmonitored prior to the addition of the protein. Then, 0.5 μMof full
length Tat (aa 1–86) or truncated Tat (aa 35–86) was added and the
CF ﬂuorescence intensity was monitored vs. time (F(t)). Even at a
lipid-to-protein ratio of only 3:1 the full length Tat protein (aa 1–86)
did not cause any CF release from the lipid vesicles (Fig. 2). In contrast,
the truncated version of the Tat protein (aa 35–86) leads to a minute
CF release of about 2%. This indicates that there is a small propensity of
the N-terminally truncated version of the Tat protein to form pores,
through which the water soluble dye CF can pass, while there is no
pore formation observable in LUVs in the presence of full length Tat.
3.2. Pore formation induced by Tat proteins in GUVs
Giant unilamellar vesicles (GUVs) have the advantage that each
individual vesicle can be inspected by confocal laser scanning
microscopy. They were doped with the membrane-embedded dye
TR-DHPE and immobilized via a membrane-conﬁned biotin anchor to
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B. Fraction of ﬁlled POPC GUVs (FrelN0.5). GUVs were incubated for 2 h without protein
(n=286), with 0.5 μM full length Tat (aa 1–86) (n=812) and with 0.5 μM of N-
terminally truncated Tat (aa 35–86) (n=284) in pyranine containing buffer (20 mM
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(FrelN0.5). GUVs were incubated for 2 h with 0.5 μM N-terminally truncated Tat (aa 35–
86) in pyranine containing buffer (n=284) (20 mM Tris/HCl, 100 mM NaCl, 200 μM
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POPC GUVs by an upright ﬂuorescence microscope. To investigate
whether the Tat proteins are capable of generating pores, through
which a water soluble dye can pass, GUVs were placed in buffer
(20 mM Tris/HCl, 100 mM NaCl, pH 7.4) containing 200 μM of the
water-soluble ﬂuorescent dye pyranine and 0.5 μM full length Tat (aa
1–86) or N-terminally truncated Tat (aa 35–86). After 2 h of
incubation, the ﬂuorescence intensity of the dye inside the GUVs
was determined using a region of interest (ROI) and normalized to
that outside of the vesicles, which is termed Frel (Fig. 3A). After 2 h, a
distribution of the ﬂuorescence intensity inside the vesicles was read
out (see supplementary information, Figure S3). To obtain a value that
reﬂects whether the vesicles are predominantly ﬁlled with the dye or
not, a threshold value of FrelN0.5 was chosen, i.e. a GUV was regarded
as dye-ﬁlled if FrelN0.5. As a control, GUVs were incubated in the dye
solution without the addition of Tat protein and Frel was read out after
2 h. For statistical analysis, at least three independent experiments
were performed. For the blank sample without Tat, 15% of the GUVs
were ﬁlled with the ﬂuorescent dye pyranine after 2 h. After
incubation with full length Tat (aa 1–86), 24% of the POPC GUVs
were ﬁlled with the dye (Fig. 3B) indicating that the majority of the
GUVs remain intact and no signiﬁcant pore formation is observed.
This is in contrast to the results obtained for Tat peptide (aa 48–57),
which has been shown to form physical pores in neutral GUV
membranes (DOPC/DPPC/Chol, 4:2:2) under buffer conditions [39]. It
is conceivable that pore formation is determined by the length of the
peptide. Already from the dye release experiments on LUVs (Fig. 2)
one can conclude that the N-terminally truncated Tat protein shows a
greater tendency to form pores. Thus, the same experiments on POPC
GUVs were performed, but full length Tat was replaced by the
truncated protein. Indeed, we found an increased entry of pyranine of
59% compared to only 24% for full length Tat (Fig. 3B). Interestingly,
even though the truncated protein is much longer (51 amino acids)
than the Tat peptide (10 amino acids), it behavesmore similarly to the
Tat peptide than to the Tat protein (86 amino acids).
As the results demonstrate that theN-terminally truncated version
of Tat induces pores in GUV membranes, we next elucidated the size
of the pores that are formed by using ﬂuorophores that are attached to
dextran molecules of different sizes. We used AlexaFluor488 attached
either to a 3 kDa large dextran (D3-AF488) or to a 10 kDa large
dextran (D10-AF488). POPC GUVs were incubated with 0.5 μM
truncated Tat (aa 35–86) in D3-AF488 and D10-AF488 containing
buffer and Frel was determined (Fig. 3C) after 2 h. In the case of D3-
AF488, more than 70% of the POPC GUVs were ﬁlled with the dye.
Even in the presence of D10-AF488, 50% of the GUVs were still ﬁlled
with the ﬂuorophore. These results demonstrate that the truncated
protein forms pores, which are large enough that amolecule of 10 kDa
can pass and they imply that it is possible for the truncated Tat proteinwith a molecular mass of 6.2 kDa to pass the membrane via such
pores.
3.3. Translocation of ﬂuorescently labeled full length Tat
In contrast to the N-terminally truncated Tat protein, the full
length protein does not signiﬁcantly form pores in lipid bilayers at a
concentration of 0.5 μM. Thus, we next investigated, whether the
protein is able to translocate across the lipid bilayer even without
forming pores. To allow for the detection of the protein position, Tat
was labeled with an AlexaFluor 633 ﬂuorescence dye (Tat-AF633).
POPC GUVs were added to a 0.5 μM solution of the labeled protein and
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its ﬂuorescence in a time resolved manner (Fig. 4). The relative
ﬂuorescence intensity was read out using two ROIs as shown in
Fig. 4A, which is plotted as a function of time as depicted in Fig. 4B.
Interestingly, no protein translocation was observed within a rather
long period of time ranging from 1 to 1.5 h. However, after that delay
time, a very fast change in ﬂuorescence intensity within the GUV is
detected and the ﬂuorescence intensity increases rapidly to the value
outside the vesicle (Frel=1). From 18 independent measurements
with Tat-AF633 in a concentration range of 0.1 μM to 1.0 μM, we were
able to determine a rate constant of k=(0.017±0.007)s−1 for the
translocation process by ﬁtting an exponential function to the data
(Fig. 4B). Within the concentration range analyzed, we did not
observe any dependency in the translocation kinetics on the Tat
protein concentration. As the assay relies on the ﬂuorescence
intensity of the Tat protein, a concentration lower than 0.1 μM could
not be used owing to the limitation of ﬂuorescence detection. We
refrained from using concentrations larger than 1 μM to be consistent
with most other studies on Tat peptide [46–48] and the release
experiments.
Of note, translocation of full length Tat-AF633 was observed
concomitantly with an increased ﬂuorescence intensity of the
ﬂuorophore at the membrane interface (Fig. 4C). Fig. 4D displays a
characteristic relative ﬂuorescence intensity proﬁle along the white
line shown in Fig. 4C. The increased ﬂuorescence intensity of Tat-
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Fig. 4. A. Fluorescence images of a POPC GUV before (set to t=0 s) and during the process of
GUVs in 20 mM Tris/HCl, 100 mM NaCl, pH 7.4. The white circles show the ROIs. Scale bars: 5
the POPC GUV during incubation with 0.5 μM full length Tat-AF633. The protein was added at
result of ﬁtting Frel=Frel,max(1−exp{−k(t− t0)}) to the data with k=0.014 s−1. C. Fluore
20 mM Tris/HCl, 100 mM NaCl, pH 7.4. As Tat-AF633 has passed the membrane, the ﬂuoresce
white line (length: 27 μm) shown in C, demonstrating the increased ﬂuorescence intensity in
AF633 in the membrane region, normalized to the ﬂuorescence intensity of Tat-AF633 outsi
ImageJ.intensity of Tat-AF633 in the environment of the GUVs revealing an
increase in ﬂuorescence intensity in the plane of the membrane by
almost 40%.
From the observation that the ﬂuorescently labeled protein Tat-
AF633 is found in the GUV lumen after 2 h, while a water-soluble dye
is excluded from the GUV interior if incubated with unlabeled full
length Tat (aa 1–86), one could conclude that the protein crosses the
membrane without pore formation. However, in the two sets of
experiments, two different proteins were used: unlabeled proteinwas
used for the elucidation of pore formation, while labeled protein was
used for the translocation assay. It is conceivable that the labeling
alters the behavior of the protein. Thus, the translocation assay was
repeated with ﬂuorescently labeled full length Tat (Tat-AF633) in the
presence of a water-soluble dye to investigate possible pore formation
(Fig. 5A). As water-soluble dye, AlexaFluor 488 was used to prevent a
crosstalk between this dye and Tat-AF633. Again, POPC GUVs were
placed in buffer containing the water-soluble dye AlexaFluor 488 and
the GUVs were incubated with 0.5 μM Tat-AF633. After 2 h, the
ﬂuorescence intensity of the water-soluble dye inside the GUVs was
determined using a region of interest (ROI) and normalized to that
outside of the vesicles. Without additional water-soluble dye, 56% of
the GUVs were found to contain Tat-AF633 (Tat-AF633, Fig. 5B I). In
the absence of the protein (free AF633, Fig. 5B II) the free dye AF633
was found in only 10% of the GUVs. However, in contrast to the results
with non-labeled full length Tat, the number of GUVs that are ﬁlled
with the water-soluble dye AF488 (AF488, Fig. 5B III) after 2 h oft / s
B
D
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Fig. 5. A. Fluorescence images of PB-DMPE doped POPC GUVs (blue) incubated with
Tat-AF633 (red) in AF488 containing buffer (green) (20 mM Tris/HCl, 100 mM NaCl,
20 nM AF488, pH 7.4), D3-AF488 containing buffer (green) (20 mM Tris/HCl, 100 mM
NaCl, 50 nM D3-AF488, pH 7.4) and D10-AF488 containing buffer (green) (20 mM
Tris/HCl, 100 mM NaCl, 50 nM D10-AF488, pH 7.4). Scale bars: 10 μm (AF488), 10 μm
(D3-AF488) and 5 μm (D10-AF488). B. Fraction of POPC GUVs with FrelN0.5 after 2 h of
incubation with 0.5 μM Tat-AF633 as a function of water soluble dye containing buffer.
Shown are the results for the blank sample of POPC GUVs incubated in AF633
containing buffer (n=217) (20 mM Tris/HCl, 100 mM NaCl, 14 μM AF633, pH 7.4),
POPC GUVs incubated with Tat-AF633 in NaCl containing buffer (n=309) (20 mM
Tris/HCl, 100 mM NaCl, pH 7.4), POPC GUVs incubated with Tat-AF633 in AF488
containing buffer (n=126) (20 mM Tris/HCl, 100 mM NaCl, 20 nM AF488, pH 7.4),
POPC GUVs incubated with Tat-AF633 in D3-AF488 containing buffer (n=182)
(20 mM Tris/HCl, 100 mM NaCl, 50 nM D3-AF488, pH 7.4) and POPC GUVs incubated
with Tat-AF633 in D10-AF488 containing buffer (n=93) (20 mM Tris/HCl, 100 mM
NaCl, 50 nM D10-AF488, pH 7.4).
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comparison see Fig. 3B). The number of Tat-AF633 ﬁlled GUVs
remains the same (Tat-AF633, Fig. 5B III). This result implies that the
attached ﬂuorophore apparently changes the behavior of the protein,
i.e. the interaction of the protein with the membrane results in pores
through which the 0.7 kDa large water-soluble dye can pass. To
elucidate the pore formation in more detail, we again made use of
ﬂuorophores attached to dextrans of different sizes. Incubation of
POPC GUVs with 0.5 μM Tat-AF633 in the presence of D3-AF488
containing buffer leads to only 21% of the GUVs that contained the
water-soluble dye D3-AF488, while again more than 50% of the GUVs
were ﬁlled with Tat-AF633 (Fig. 5B IV). If the size of the dextran was
increased to 10 kDa, only very few GUVs (7%) were found to be ﬁlled
with the dye, while again about 60% of the GUVs were ﬁlled with Tat-
AF633 (Fig. 5B V).These results indicate that labeled Tat-AF633 does form pores in
membranes but the pores are rather small. The fact that the dye
transfer of the 3 kDa large dextran molecule is already strongly
hindered compared to the neat AF488 dye suggests that the pores are
much smaller than the size of full length Tat with a mass of 10.3 kDa
(11.6 kDa for full length Tat-AF633). This is in contrast to the N-
terminally truncated Tat, where the 10 kDa dextran molecule passes
themembrane to the same extent as the free dye, which demonstrates
that the truncated Tat protein forms signiﬁcantly larger pores
(Fig. 3C).
We asked the question whether the translocation of the protein
occurs simultaneously with the dye transfer or whether translocation
can be observed without the transfer of intermediate sized dextran-
coupled ﬂuorophore. To analyze this, ﬂuorescence images of Tat-
AF633 and POPC GUVs in D3-AF488 containing buffer were taken in a
time dependent manner. At t=0 h, POPC GUVs are neither ﬁlled with
D3-AF488 (green) nor with Tat-AF633 (red). After 1 h, Tat-AF633
started to translocate across the membrane into the POPC GUV lumen
indicated by the increasing ﬂuorescence intensity of Tat-AF633 inside
the GUV. However, D3-AF488 still remains outside the GUV. After 2 h,
the Tat concentration inside equals that outside, while the ﬂuor-
ophore D3-AF488 still remains outside. This demonstrates that not the
translocation of the 11.6 kDa protein itself leads to the entry of the
3 kDa large water-soluble dye in the GUVs. The very small dye AF488
with a mass of 0.7 kDa, however translocates simultaneously with the
protein suggesting that small perturbations within the membrane
occur while the protein passes the membrane.
4. Discussion
Our results suggest that native full length Tat (aa 1–86) does not
form pores in unilamellar POPC vesicles under physiological buffer
conditions. We found neither a dye release from LUVs, even at very
large protein concentrations, nor a dye entry into GUVs induced by
full length Tat. In contrast, the N-terminally truncated Tat protein (aa
35–85) that lacks the proline-rich and cysteine-rich region is capable
of forming pores in POPC LUVs and POPC GUVs. However, pore
formation in POPC LUVs induced by truncated Tat was only minute. It
was more signiﬁcant in GUVs with pore sizes that allowed a 10 kDa
sized dextran to enter the vesicle interior. This implies that also the N-
terminally truncated protein with a mass of 6.2 kDa can in principle
pass the membrane via induced pores.
This is different from the results obtained by the group of
Kubitscheck [39]. They have shown that micromolar concentrations
of Tat peptide form 1–2 nm large pores in GUVs (containing
phosphatidylethanolamine, PE, or phosphatidylserine, PS) through
which 3 kDa large dyes can pass but not 10 kDa large ones. These
results were obtained in the absence of ions and no pore formation
was observed in neutral phosphatidylcholine (PC) membranes. In PBS
buffer, the situation was quite different. Here, the group reported [39]
that Tat peptide translocation occurs even through neutral lipid
membranes (DOPC/DPPC/Chol, 4:4:2) with a concomitant efﬂux of
the water soluble dye Alexa488 demonstrating that very small pores
are formed by the Tat peptide in the presence of ions. The results
suggest that the mechanism of Tat peptide translocation might be
associated with its pore formation capability, which is supported by
molecular dynamics simulations. Herce and Garcia [27] demonstrated
that the Tat peptide interacts with the phosphate head groups of the
lipid bilayer on both sides, resulting in an insertion of the charged side
chains of the peptide, thus nucleating the formation of a transient
pore, followed by the translocation of the Tat peptide. Further
evidence into this direction is given by Mishra et al. [38], who found
that the Tat peptide induced a saddle-splay curvature in PC/PE/PS
(2:2:1) membranes of a GUV resulting in pores through which the
peptide could enter the interior. In contrast, pore formation induced
by the Tat peptide was not observed in LUV membranes composed of
A
t = 0 h t = 0 h t = 0 h
t = 0 h
t = 1 h t = 1 h t = 1 h
t = 1 h
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physiological conditions. Translocation of the Tat peptide into LUVs in
the presence of ions was also not found, neither in neutral PC-
membranes nor in negatively charged PC/PG-membranes [40,49].
These ﬁndings point in the direction that membrane curvature might
play a central role in pore formation.
Pore formation cannot be attributed only to the basic Tat peptide
(aa 48–57). As we observed no pore formation in GUV and LUV POPC
membranes for the full length protein under buffer conditions but for
the N-terminally truncated protein, other structural contributions
appear to be decisive, as both proteins contain the ARM. One major
difference between full length and truncated protein is the N-
terminus (aa 1–34). The N-terminus is a structurally ordered region
as deduced from the crystal structure of the protein in complex with
human P-TEFb [43]. In the absence of a stabilizing co-factor, the
proline-rich region of Tat is supposed to be rather ﬂexible and folded
as a random coil [36,50], whereas the cysteine-rich region might
adopt a more compact fold by the formation of one or two zinc ﬁnger
motifs [43]. The N-terminus also contains a conserved tryptophan
residue at position 11, by which Tat has been shown to be able to
insert into lipid membranes [31]. It is conceivable that the ordered
structure in conjunction with the tryptophan residue orients the
inserted protein in neutral lipid bilayers, which thus prevents pore
formation. The truncated Tat protein (aa 35–86) as well as the Tat
peptide are more ﬂexible and lack the tryptophan residue, which
might result in a less ordered structure in neutral lipid bilayers, so that
pore formation is favored in the presence of buffer. It has been shown
that even though the arginine-rich motif appears to be folded, it is
structurally very ﬂexible. When bound to TAR, it adopts an α-helical
fold in full length Tat [51], but an anti-parallel β-strand like structure
was determined for a short peptide, which corresponds to the Tat cell
penetrating peptide [51–53]. These different conformations depend-
ing on the molecular co-factors indicate the ﬂexibility and dynamics
of the Tat translocation sequence. Another aspect to be considered
might be the overall charge density at physiological pH, which is
lowest for full length Tat (aa 1–86) (pI=9.7) followed by the N-
terminally truncated protein (aa 35–86) (pI=11.3) and largest for
the cell penetrating Tat peptide (aa 48–57) (pI=12.7). A higher
charge density might also facilitate pore formation. This is however,
not reﬂected in the size of the pores. Pore sizes reported by Ciobanasu
et al. [39] are a little smaller than the sizes we found for truncated Tat
protein (aa 35–86). There was no or only a certain efﬂux of the 3 kDa
dextran coupled dye, while we found that a 10 kDa dextran coupled
dye could pass the membrane when the GUVs are incubated with
truncated Tat (aa 35–86).
Fluorescence labeling of full length Tat (Tat-AF633) enabled us to
investigate whether this protein is able to cross lipid membranes.
Interestingly, Tat-AF633 is capable of translocating across POPC GUV
membranes. In contrast to the non-labeled full length protein, it forms
small pores, through which the water-soluble dye AF488 can pass.
However, the pores themselves are not large enough for a 10 kDa
dextran molecule to access the inner compartment of the vesicle,
which suggests that the labeled protein with a molecular mass of
11.6 kDa does not cross the membrane via these pores. This ﬁnding is
supported by the observation that the labeled protein passes the POPC
membrane of a GUV without a transfer of the 3 kDa large dextran
molecule (Fig. 6).Fig. 6. Fluorescence images of PB-DMPE doped POPC GUVs with Tat-AF633 (red) in D3-
AF488 containing buffer (green) (20 mM Tris/HCl, 100 mM NaCl, 50 nM D3-AF488, pH
7.4) at A. t=0 h, B. t=1 h and C. t=2 h. Scale bars: 20 μm. The relative intensity
proﬁles along the white lines show the ﬂuorescence intensities of D3-AF488 (green)
and Tat-AF633 (red), each normalized to the ﬂuorescence intensity outside the GUV.
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membrane. Such accumulation will probably disturb the integrity of
the membrane, which might favor small pores to be formed.
Moreover, such accumulation might explain why there is no
concentration dependence of Tat entry in the vesicle in a concentra-
tion range of 0.1–1.0 μM. It is assumed that the protein concentration
within the membrane and not outside the membrane is decisive for
the translocation to occur. Curnow et al. [47] also found that labeled
Tat peptide accumulates in the membrane of 5 μm sized DOPC
vesicles. The assumption that the protein requires a certain local
concentration in the membrane of the GUV to pass the bilayer would
explain why there is a delay between protein addition and
translocation. It is conceivable that Tat forms oligomers in the
membrane, as observed by Tosi et al. [54], which leads to the
observed accumulation and eventually to the protein transfer. Further
evidence for an insertion of the protein in lipid bilayers is given by
Yezid et al. [31], who demonstrated that full length Tat inserts into
lipid monolayers and vesicles at pH 6.0. They attributed the insertion
of Tat to the highly conserved tryptophan residue in position 11,
which is not present in truncated Tat (aa 35–86) or the Tat peptide
(aa 48–57) and might explain why the shorter Tat versions behave
differently compared to the full length protein.
In several studies, ﬂuorescently labeled Tat peptide was used to
investigate its interaction with lipidmodel membranes [38–40,46,47].
Of note, our experiments demonstrate that native full length Tat
behaves differently than ﬂuorescently labeled full length Tat. Only the
ﬂuorescently labeled version generates small pores in GUV mem-
branes. This indicates that the ﬂuorescent dye might inﬂuence the
protein structure and thus its interaction with the membrane.5. Conclusions
The translocation of full length Tat has been investigated bymeans
of ﬂuorescence spectroscopy and ﬂuorescence microscopy leading to
the conclusion that the protein does not form pores in LUVs and GUVs,
while a truncated version of the protein lacking the ordered proline-
and cysteine-rich region forming a zinc ﬁnger motif is able to form
pores in neutral membranes. This result lets us conclude that not only
the basic cluster referred to as the Tat cell penetration peptide
determines whether pores are formed but rather the overall charge
density of the protein and its global ﬂexibility. Full length Tat is
capable of translocating across a neutral GUV membrane under
physiological conditions. However, the attached ﬂuorescent dye alters
the interaction of the protein with the membrane. It results in a
disturbance of the lipid bilayer so that small molecules can enter the
vesicle interior. In contrast, molecules of a size similar to that of the
protein itself do not enter the vesicle's lumen. These results illustrate
that the translocation mechanism is not directly dependent on the
pore formation process but presumably relies on an accumulation of
the protein in the membrane, which produces a disturbance of the
membrane structure to let the protein through.Acknowledgment
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